NCT00595426View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

685

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Arthroplasty, Replacement, Knee
Interventions
DRUG

YM150

Oral

DRUG

Warfarin

Oral

Trial Locations (54)

20017

Washington D.C.

21218

Baltimore

23249

Richmond

23294

Richmond

29414

Charleston

30033

Decatur

31405

Savannah

32561

Gulf Breeze

33021

Hollywood

33703

St. Petersburg

33713

St. Petersburg

33744

Bay Pines

34209

Bradenton

36608

Mobile

44195

Cleveland

45242

Cincinnati

62703

Springfield

62794

Springfield

72205

Little Rock

74146

Tulsa

75231

Dallas

76051

Grapevine

77030

Houston

78217

San Antonio

78229

San Antonio

78745

Austin

79410

Lubbock

79412

Lubbock

79761

Odessa

80012

Aurora

80124

Lone Tree

80230

Denver

83404

Idaho Falls

83702

Boise

85023

Phoenix

85712

Tuscon

90502

Torrance

90806

Long Beach

90822

Long Beach

91942

La Mesa

92074

Santa Ana

92128

San Diego

92708

Fountain Valley

95991

Yuba City

T4N 4E7

Red Deer

L1S 2J5

Ajax

L7R 4B7

Burlington

H1T 2M4

Montreal

L3Y 2P9

Newmarket

L2R 7P3

Saint Catherines

M1E 5E9

Scarborough Village

P7B 6V4

Thunder Bay

N2J 1CA

Waterloo

C1A 1L2

Charlottetown

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY